HK1054327B - 用於治療尿道疾病的透皮給藥裝置 - Google Patents

用於治療尿道疾病的透皮給藥裝置

Info

Publication number
HK1054327B
HK1054327B HK03106545.4A HK03106545A HK1054327B HK 1054327 B HK1054327 B HK 1054327B HK 03106545 A HK03106545 A HK 03106545A HK 1054327 B HK1054327 B HK 1054327B
Authority
HK
Hong Kong
Prior art keywords
group
substituted
alkyl
phenyl
halogen atoms
Prior art date
Application number
HK03106545.4A
Other languages
English (en)
Other versions
HK1054327A1 (en
Inventor
Dressen Frank
Schacht Dietrich
Wolff Hans-Michael
Original Assignee
Ucb Pharma Gmbh
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Pharma Gmbh, Kissei Pharmaceutical filed Critical Ucb Pharma Gmbh
Publication of HK1054327A1 publication Critical patent/HK1054327A1/xx
Publication of HK1054327B publication Critical patent/HK1054327B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • External Artificial Organs (AREA)
HK03106545.4A 2001-09-14 2003-09-11 用於治療尿道疾病的透皮給藥裝置 HK1054327B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01121687A EP1293198B1 (en) 2001-09-14 2001-09-14 Device for transdermal administration for the treatment of urinary tract disorders

Publications (2)

Publication Number Publication Date
HK1054327A1 HK1054327A1 (en) 2003-11-28
HK1054327B true HK1054327B (zh) 2005-07-29

Family

ID=8178599

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03106545.4A HK1054327B (zh) 2001-09-14 2003-09-11 用於治療尿道疾病的透皮給藥裝置

Country Status (9)

Country Link
US (1) US20050226919A1 (zh)
EP (1) EP1293198B1 (zh)
AT (1) ATE288745T1 (zh)
DE (1) DE60108870T2 (zh)
DK (1) DK1293198T3 (zh)
ES (1) ES2237515T3 (zh)
HK (1) HK1054327B (zh)
PT (1) PT1293198E (zh)
WO (1) WO2003024432A2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1806136E (pt) * 2004-10-06 2012-03-08 Kissei Pharmaceutical Composição medicamentosa para a prevenção da transição para o tratamento operatório da hipertrofia prostática
DE602006003813D1 (de) * 2005-06-06 2009-01-08 Fujimoto Co Ltd Pharmazeutische Zusammensetzung zur perkutane Absorption unter Verwendung von einem Metalchlorid, vorzugsweise Natriumchlorid, zur Vorbeugung von Kohäsionsschwäche
JP5813652B2 (ja) * 2010-10-28 2015-11-17 久光製薬株式会社 経皮吸収型製剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0588839B1 (de) * 1991-06-10 1995-08-16 Schwarz Pharma Ag Nitroglycerin-pflaster und verfahren zu seiner herstellung
EP0600675B1 (en) * 1992-12-02 1998-07-08 Kissei Pharmaceutical Co., Ltd. Indoline compounds for the treatment of dysuria
IL120303A0 (en) * 1996-03-27 1997-06-10 Pfizer Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
IL120302A0 (en) * 1996-03-27 1997-06-10 Pfizer Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
AU3011299A (en) * 1998-03-23 1999-10-18 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia
US6541669B1 (en) * 1998-06-08 2003-04-01 Theravance, Inc. β2-adrenergic receptor agonists

Also Published As

Publication number Publication date
ATE288745T1 (de) 2005-02-15
WO2003024432A2 (en) 2003-03-27
EP1293198B1 (en) 2005-02-09
PT1293198E (pt) 2005-06-30
HK1054327A1 (en) 2003-11-28
WO2003024432A3 (en) 2003-09-04
ES2237515T3 (es) 2005-08-01
DK1293198T3 (da) 2005-06-06
US20050226919A1 (en) 2005-10-13
DE60108870D1 (de) 2005-03-17
EP1293198A1 (en) 2003-03-19
DE60108870T2 (de) 2005-07-28

Similar Documents

Publication Publication Date Title
HK1116766A1 (en) 5-substituted-2-phenylamino-benzamides as mek inhibitors
NO922942D0 (no) Terapeutiske amider
DK1351722T3 (da) Knogleimplantat
ATE384524T1 (de) Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
FI954243A0 (fi) Farmaseuttiset yhdisteet
DK1463487T3 (da) Liposomal afgivelse af vitamin-E baserede forbindelser
ATE357453T1 (de) Comt-inhibitoren
HK1054327A1 (en) Device for transdermal administration for the treatment of urinary tract disorders.
IT1317031B1 (it) Procedimento migliorato per la preparazione di (e,z)3-(2-amminoetossimmino)-androstano-6, 17-dione e di suoi analoghi.
EP1806136A4 (en) THERAPEUTIC PREPARATION TO ELIMINATE THE TRANSITIONAL STEP TOWARDS THE OPERATIVE TREATMENT OF PROSTATIC HYPERTROPHY
MXPA05008923A (es) Compuestos de triazol utiles en terapia.
WO2003024950A1 (fr) Dérivé de coumarine
TW366283B (en) Compounds for treatment of arrhythmia
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
DE60000556D1 (de) Tetrazolylalkyl-Indolderivate als entzündungshemmende und analgetische Mittel
EA199900570A1 (ru) Гипоталамо-гипофизарное средство, вызывающее устойчивую стадию торможения и/или покоя у собак и стадию покоя у кошек (анэструс)

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110914